Search

Organic microfossils in Meso- and Neoproterozoic rocks are of key importance to track the emergence and evolution of eukaryotic life. An increasing number of studies combine Raman spectroscopy with synchrotron-based methods to characterize these microfossils. A recurring observation is that Raman spectra of organic microfossils show negligible variation on a sample scale and that variation between different samples can be explained by differences in thermal maturation or in the biologic origin of organic precursor material. There is a paucity of work, however, that explores the extent to which the petrographic framework and diagenetic processes might influence the chemical structure of organic materials. We present a detailed Raman spectroscopy-based study of a complex organic microfossil assemblage in the ca. 1 Ga old Angmaat Formation, Baffin Island, Canada. This formation contains abundant early diagenetic chert that preserves silicified microbial mats with numerous, readily identifiable organic microfossils. Individual chert beds show petrographic differences with discrete episodes of cementation and recrystallization. Raman spectroscopy reveals measurable variation of organic maturity between samples and between neighboring organic microfossils of the same taxonomy and taphonomic state. Scanning transmission X-ray microscopy performed on taphonomically similar coccoidal microfossils from the same thin section shows distinct chemical compositions, with varying ratios of aromatic compounds to ketones and phenols. Such observations imply that geochemical variation of organic matter is not necessarily coupled to thermal alteration or organic precursor material. Variation of the Raman signal across single samples is most likely linked to the diagenetic state of analyzed materials and implies an association between organic preservation and access to diagenetic fluids. Variation in the maturity of individual microfossils may be a natural outcome of local diagenetic processes and potentially exceeds differences derived from precursor organic material. These observations stress the importance of detailed in situ characterization by Raman spectroscopy to identify target specimens for further chemical analysis., (© 2021 John Wiley & Sons Ltd.)

The occurrence of microfossiliferous, early diagenetic chert in Proterozoic successions is broadly restricted to peritidal marine environments. Such coastal environments are amongst the most environmentally variable of marine environments, experiencing both enhanced evaporation and potential influx of terrestrial freshwaters. To better understand potential conditions under which silicification occurs, we focus on microfossiliferous early diagenetic chert from the Mesoproterozoic Bylot Supergroup, northern Baffin Island. Spectacular preservation of silicified microbial mats, their associated mineral phases, and the petrographic fabrics of the chert itself require that silicification occurred at the sediment-water interface, penecontemporaneously with mat growth. In some cases, silica is the primary precipitated mineral phase and is not associated with replacement of precursor mineral phases. In other cases, silica deposition includes the mimetic replacement of carbonate, gypsum, and halite mineral phases. These petrographic constraints suggest that silicification potentially occurred under a range of fluid chemistries associated with environmental variability in nearshore peritidal environments. Here we provide the first direct thermodynamic modeling of hypothetical Proterozoic seawater solutions, seawater-derived brines, and mixed seawater-freshwater solutions, and demonstrate that peritidal environments are capable of providing a wide range of fluid chemistries under which early diagenetic silica can both precipitate and replace primary mineralogical phases. Despite the thermodynamic potential for silica deposition under a wide range of fluid compositions, chert is not ubiquitous in Proterozoic nearshore environments, suggesting that the kinetics of silica polymerization exert a primary control over deposition., (© 2017 John Wiley & Sons Ltd.)

Background: Shark cartilage has been a popular complementary or alternative medicine intervention. The basis for this popularity is the claim that sharks rarely get cancer because of the high proportion of cartilage in the shark's body. However, early studies were equivocal. Therefore, a clinical trial was conducted to look at the impact of shark cartilage in patients with advanced cancer. The primary goal of this trial was to determine whether a shark cartilage product improved overall survival for patients with advanced cancer who were getting standard care. Secondary research goals were to evaluate toxicities, tolerability, and quality of life associated with this shark cartilage product., Methods: The study was a two-arm, randomized, placebo-controlled, double-blind, clinical trial. Patients with incurable breast or colorectal carcinoma had to have good performance status and organ function. Patients could be receiving chemotherapy. Patients were all to receive standard care and then to be randomly selected to receive either a shark cartilage product or an identical-appearing and smelling placebo 3 to 4 times each day., Results: Data on a total of 83 evaluable patients were analyzed. There was no difference in overall survival between patients receiving standard care plus a shark cartilage product versus standard care plus placebo. Likewise, there was no suggestion of improvement in quality of life for patients receiving the shark cartilage, compared with those receiving placebo., Conclusion: This trial was unable to demonstrate any suggestion of efficacy for this shark cartilage product in patients with advanced cancer.

The unique case of a 60-year-old patient with a non-Hodgkin's B-cell lymphoma of the lymphoplasmacytic type and three associated monoclonal proteins, is described. The patient also exhibited various autoimmune phenomena that were consistent with the diagnoses of Sjögren's syndrome and autoimmune thyroiditis. The evolution from production of a single monoclonal protein (IgM-kappa) to three monoclonal proteins (IgG-kappa, IgA-kappa, and IgM-kappa) suggested that the lymphoplasmacytic cells were at different stages of terminal differentiation within a single neoplastic clone. The chronic antigenic stress imposed on the immune system by the autoimmune disorder may have played a role in the development of lymphoma and in the heavy chain immunoglobulin switching that occurred during the patients' clinical course.